Evidence map›Paper›PMID 32927647›Full record

ArticleJournal of clinical medicine2020

Melatonin Improves Mitochondrial Dynamics and Function in the Kidney of Zücker Diabetic Fatty Rats.

Ahmad Agil, Meriem Chayah, Lucia Visiedo, Miguel Navarro-Alarcon, José Manuel Rodríguez Ferrer, Mohamed Tassi, Russel J Reiter, Gumersindo Fernández-Vázquez

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ahmad AgilDepartment of Pharmacology and Neurosciences Institute, School of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0003-0164-9648
Meriem ChayahDepartment of Pharmacology and Neurosciences Institute, School of Medicine, University of Granada, 18016 Granada, Spain.
Lucia VisiedoDepartment of Pharmacology and Neurosciences Institute, School of Medicine, University of Granada, 18016 Granada, Spain.
Miguel Navarro-AlarconDepartment of Nutrition and Bromatology, School of Pharmacy, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-3189-3310
José Manuel Rodríguez FerrerDepartment of Physiology, School of Medicine, University of Granada, 18016 Granada, Spain.
Mohamed TassiService of Microscopy, CIBM, University of Granada, 18016 Granada, Spain.
Russel J ReiterDepartment of Cellular and Structural Biology, University of Texas Health Science at San Antonio, San Antonio, TX 78229, USA.
Gumersindo Fernández-VázquezService of Endocrinology, La Paz Hospital, 28046 Madrid, Spain.
Universidad de Granada · ESHospital Universitario La Paz · ESThe University of Texas Health Science Center at San Antonio · US

Funding

Ministerio de Economía y Competitividad (Spain) SAF2016-79794-R
6 · The paper itself

Abstract

Obesity and associated diabetes (diabesity) impair kidney mitochondrial dynamics by augmenting fission and diminishing fusion, which results in mitochondrial and renal dysfunction. Based on available evidence, the antioxidant activities of melatonin may improve impaired renal mitochondrial function in obese diabetic animals by restoring the imbalanced dynamics through inhibiting fission and promoting fusion. Male Zücker diabetic fatty (ZDF) rats and lean littermates (ZL) were orally treated either with melatonin (10 mg/kg BW/day) (M-ZDF and M-ZL) or vehicle (C-ZDF and C-ZL) for 17 weeks. Kidney function was evaluated by measurement of total urine volume, proteinuria, creatinine clearance, and assessment of kidney mitochondrial dynamics and function. C-ZDF exhibited impaired dynamics and function of kidney mitochondria in comparison to C-ZL. Melatonin improved nephropathy of ZDF rats and modulated their mitochondrial dynamics by reducing expression of Drp1 fission marker and increasing that of fusion markers, Mfn2 and Opa1. Furthermore, melatonin ameliorated mitochondrial dysfunction by increasing respiratory control index and electron transfer chain complex IV activity. In addition, it lowered mitochondrial oxidative status. Our findings show that melatonin supplementation improves nephropathy likely via modulation of the mitochondrial fission/fusion balance and function in ZDF rats.

Indexed as

diabetesDrp1fission/fusionmelatoninMfn2mitochondrial function/dynamicnephropathyobesityOpa1ZDF rats

Identifiers

PMID32927647
PMCPMC7564180
OpenAlexW3084412948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.